Biotechnology Cellectis and AstraZeneca in US$2.2bn deal AstraZeneca plc has paid French cancer cell therapy developer Cellectis SA US$25m upfront and US$220m in equity in an US$2.2bn R&D deal for up to ten cell and gene therapies. Under the co-development agreement, that includes a US$80m equity investment and an option for a further equity investment of US$140m by AstraZeneca plc into Cellectis […] Written by BIOCOM AG November 1, 2023November 1, 2023 Saving Bookmark this article Bookmarked
Biotechnology Pfizer RSV vaccine gets off to fast start on market The pharma’s shot Abrysvo made over $300 million in sales during the first few months of its launch, and will be an important product to help offset declining COVID vaccine sales. Written by Delilah Alvarado October 31, 2023October 31, 2023 Saving Bookmark this article Bookmarked
Biotechnology Advancements in In Silico ADMET Modeling: A 20-Year Journey of Machine Learning in Drug Discovery at Bayer Pharma – DrugPatentWatch Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Over the past two decades, Bayer Pharma has developed an in silico absorption, distribution, metabolism, and excretion (ADMET) platform with the aim of generating models for various pharmacokinetic and physicochemical endpoints in early drug discovery. This platform is accessible to all scientists within the company and has proven […] Written by DrugPatentWatch October 30, 2023October 30, 2023 Saving Bookmark this article Bookmarked
Biotechnology Engineers from the UMA develop more accessible and versatile next-gen The next-gen “digital twins” are created at the University of Malaga. Three engineers from the research group “ERTIS” have developed an open-source platform, more accessible and versatile, that enables the design of these technological tools that simulate real environments based on virtual replicas. The next-gen “digital twins” are created at the University of Malaga. Three […] Written by Bioengineer October 29, 2023October 29, 2023 Saving Bookmark this article Bookmarked
Biotechnology major antitrust cases in recent years Antitrust laws are put in place to prevent unlawful activities like price fixing, as well as monopolies from forming, typically tied to big pharma. If these powerful companies were to swallow smaller biotechs in an attempt to fix prices, it would stifle competition, result in limited options for consumers, thereby leading to a rise in […] Written by Roohi Mariam Peter October 28, 2023October 28, 2023 Saving Bookmark this article Bookmarked
Biotechnology BioNtech reports Car-T/mRNA booster study results at ESMO BioNtech SE has reported preliminary Phase I/II results with BNT211-01 (NEO-PTC-01) and CarVAC at ESMO conference in Madrid Testing different dose levels of its adoptive cell therapy BNT.221-01, a combination of Claudin 6 (CLDN6)-targeted Car-T cells (derived from NEO-PTC-01, initially developed by tody’s BioNTech subsidiary Neon Therapeutics) and the mRNA-based Car-T booster CarVac (CAR-T cell […] Written by BIOCOM AG October 27, 2023October 27, 2023 Saving Bookmark this article Bookmarked
Biotechnology Eisai says new data could support more convenient form of Alzheimer’s drug Leqembi An under-the-skin injection of Leqembi performed about the same as the already marketed intravenous form, according to trial results presented Wednesday. A new approval application is expected by the end of March. Written by Jacob Bell October 26, 2023October 26, 2023 Saving Bookmark this article Bookmarked
Biotechnology Drug Patent Expirations for the Week of October 22, 2023 – DrugPatentWatch Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ FINACEA (azelaic acid) Leo pharma as Patent: 8,900,554 Expiration: Oct 24, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com Make Better Decisions with DrugPatentWatch » Start Your Free Trial Today « Copyright © […] Written by DrugPatentWatch – Make Better Decisions October 25, 2023October 25, 2023 Saving Bookmark this article Bookmarked
Biotechnology Preventing airborne infection without impeding communication with ions and A novel device developed by researchers from Tokyo Institute of Technology, Tokyo Medical and Dental University, and Chiba University in a new study utilizes ions and an electric field to effectively capture infectious droplets and aerosols, while letting light and sound pass through to allow communication. The innovation is significant in the wake of the […] Written by Bioengineer October 24, 2023October 24, 2023 Saving Bookmark this article Bookmarked
Biotechnology Is Africa set to become a pharma and vaccine manufacturing hub? Localizing pharma manufacturing worldwide is an extremely important step, and it holds particular significance for Africa. The continent is more vulnerable to disease burdens and lags behind other continents when it comes to vaccine and general healthcare access. Localized manufacturing could help people in Africa gain easier and more affordable access to vaccines and other […] Written by Willow Shah-Neville October 22, 2023October 22, 2023 Saving Bookmark this article Bookmarked
A cholesterol secret inside ticks may halt Lyme disease spread Washington State University researchers have discovered how the bacteria that cause anaplasmosis and Lyme disease hijack cellular processes in ticks to ensure their survival and spread to new hosts, including humans. Based in the College of Veterinary Medicine, the team found that the bacteria can manipulate a protein known as ATF6, which helps cells detect […] Written by Admin July 6, 2025July 6, 2025 Saving Bookmark this article Bookmarked
Unicycive Therapeutics Announces Receipt of Complete Response Letter for Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis LOS ALTOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease… Written by Admin July 5, 2025July 5, 2025 Saving Bookmark this article Bookmarked
A cholesterol secret inside ticks may halt Lyme disease spread Washington State University researchers have discovered how the bacteria that cause anaplasmosis and Lyme disease hijack cellular processes in ticks to ensure their survival and spread to new hosts, including humans. Based in the College of Veterinary Medicine, the team found that the bacteria can manipulate a protein known as ATF6, which helps cells detect […] Written by Admin July 6, 2025July 6, 2025 Saving Bookmark this article Bookmarked
Unicycive Therapeutics Announces Receipt of Complete Response Letter for Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis LOS ALTOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease… Written by Admin July 5, 2025July 5, 2025 Saving Bookmark this article Bookmarked
Robotic Probe Rapidly Assesses Essential Properties of Novel Materials In the quest to conquer the limitations of semiconductor materials and their application in solar technologies, a pioneering research team at the Massachusetts Institute of Technology (MIT) has developed an innovative autonomous robotic system. This advancement comes at a crucial time when the demand for efficient energy sources continues to rise. Researchers face significant bottlenecks […] Written by Bioengineer July 5, 2025July 5, 2025 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked